Sign in

CIK 0000926617

  • Non-accelerated filer
  • Smaller reporting company

Aspira Women's Health Inc.

Sign in to watch
Ticker
AWHL
Exchange
OTC
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
330595156
Phone
+1 512-519-0400
Business address
12117 BEE CAVES ROAD BUILDING THREE, SUITE 100, AUSTIN, TX, 78738
Former names
VERMILLION, INC., CIPHERGEN BIOSYSTEMS INC
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Grant or award Director acquired 15,680 shares (grant or award)
  4. 4 Grant or award Director acquired 16,442 shares (grant or award)
  5. 4 Grant or award Director acquired 4,031 shares (grant or award)
  6. 4 Grant or award Director acquired 9,205 shares (grant or award)
  7. 3 Insider Initial Statement of Ownership
  8. 3 Insider Initial Statement of Ownership
  9. 4 Open-market sale Director sold 50,000 shares at $2.78 ($139,000)
  10. 4 Insider Changes in Ownership
  11. 4 Open-market buy 10% owner bought 2,285,715 shares at $3.50 ($8,000,003)
  12. 4 Option exercise 10% owner acquired 730,560 shares (option exercise)
  13. 4 Option exercise 10% owner acquired 463,298 shares (option exercise)
  14. 4/A Option exercise Director acquired 5,021 shares (option exercise)
  15. 4 Option exercise President and CEO acquired 7,531 shares (option exercise)
  16. 4 Option exercise Director acquired 11,250 shares (option exercise)
  17. 4 Option exercise Director acquired 5,021 shares (option exercise)
  18. 4 Option exercise Director acquired 5,210 shares (option exercise)
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 10 of 28 · 551 filings